S22-068 Amphiregulin nanobodies to prevent the development of fibroatheromas Researchers at Stanford have discovered that nanobodies blocking amphiregulin (AREG) activity have the potential to impede the progression of early-stage atherosclerotic plaque lesions to advanced-stage fibroatheromas. Patricia Nguyen Charles Chan Mark Davis